Abstract:Background: Biomarkers of myocardial injury and inflammation were found to be different after radiofrequency catheter ablation (RFCA) and cryoballoon ablation (CBA) for atrial fibrillation (AF); however, the results are currently controversial. This study was aimed to systematically compare the differences in myocardial injury and inflammation biomarkers after RFCA and CBA procedures and to investigate their impact on AF recurrence. Methods: Databases, including PubMed, Embase, the Cochrane Library, ClinicalTrials.gov, China National Knowledge Infrastructure (CNKI) and China Biology Medicine (CBM), were systematically searched from their date of inception to May 2022. The primary outcomes of interest were the differences in myocardial injury and inflammation biomarkers after CBA and RFCA procedures for AF patients, and the impact of the biomarkers on AF recurrence. Secondary outcomes included the total ablation time, the procedure duration and the freedom from atrial tachycardia (AT). Results: Eighteen studies with a total of 1807 patients were finally enrolled. CBA treatment was associated with significantly greater increases in troponin I (TNI) levels (weighted mean difference [WMD] = 3.13 ug/L, 95% confidence interval [CI] 2.43-3.64) both at 4-6 h (WMD = 3.94 ug/L), 24 h (WMD = 4.23 ug/L), 48 h (WMD = 2.14 ug/L) and 72 h (WMD = 0.56 ug/L), and also creatine kinade MB fraction (CK-MB) levels at 4-6 h (WMD = 33.21 U/L), 24 h (WMD = 35.84 U/L) and 48 h (WMD = 4.62 U/L), while RFCA treatment was associated with greater increases in postablation C-reactive protein (CRP) levels both at 48 h (WMD = -9.32 mg/L) and 72 h (WMD = -10.90 mg/L). The CBA and RFCA treatments had comparable rates of freedom from AT (74.5% vs. 75.2%, RR = 1.08). The CRP levels were significantly higher in patients with early recurrence of AF (ERAF) than in those without ERAF after RFCA treatment (WMD = 3.415 mg/L). Conclusions: The time-course patterns of postablation myocardial injury and inflammation biomarkers are different between RFCA and CBA procedures. The lower postprocedural elevation of myocardial injury biomarkers and the increased CRP levels may be predictive factors for ERAF.

The dynamic evolution characteristics of myocardial injury and inflammation biomarkers after cryoballoon ablation for atrial fibrillation

Comparison of Myocardial Injury and Inflammation Biomarkers and Their Impact on Recurrence after Cryoballoon and Radiofrequency Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis

The comparison and clinical significance of myocardial injury between the atrial fibrillation patients treated with radiofrequency ablation and cryoballoon ablation

Myocardial Injury Resulting from Radiofrequency Catheter Ablation: Comparison of Circumferential Pulmonary Vein Isolation and Complex Fractionated Atrial Electrograms Ablation.

Effects of catheter ablation of atrial fibrillation on the biomarker profile

P6597Long-term Impact of Catheter Ablation on Growth Differentiation Factor-15 and Neutrophil-Lymphocyte Ratio in Paroxysmal Atrial Fibrillation

Short and Long-Term Changes in Platelet and Inflammatory Biomarkers after Cryoballoon and Radiofrequency Ablation.

Evaluation the changes of cTNI,CK-MB and MYO after atrial fibrillation radiofrequency cathether ablation

Early Recurrence after Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation: Mechanism and Implication in Long-Term Outcome

Impact of different energy sources on coagulation biomarkers and silent cerebral events in balloon-based ablation for atrial fibrillation

Clinical Study on Serum Levels of Myocardical Enzymes Before and after Catheter Ablation in Patients with Atrial Fibrillation

Evaluation of CK-MB and hs-CRP before and after radiofrequency catheter ablation

The change of MYO,TNI and CK-MB before and after therapy in atrial fibrillation patients after RFCA

Long-term clinical outcome of cryoballon ablation in treatment of paroxysmal atrial fibrillation

Analysis of 12 Cases of Atrial Fibrillation Treated by Cryoballoon Catheter Ablation

Cryoballoon Ablation In Chinese Patients With Paroxysmal Atrial Fibrillation: 1-Year Follow-Up

Association between pericoronary adipose tissue attenuation and outcome after second-generation cryoballoon ablation for atrial fibrillation

Comprehensive analysis of recurrence factors in cryoballoon AF ablation: integrating clinical, biomarkers, and echocardiographic parameters

Multiple Biomarkers and Arrhythmia Outcome Following Catheter Ablation of Atrial Fibrillation: the Guangzhou Atrial Fibrillation Project

The Investigations of Atrial Fibrillation Burden after Cryoballoon Ablation Detected by Insertable Cardiac Monitor in Patients with Paroxysmal Atrial Fibrillation: A Study Protocol for a Multicenter Randomized Controlled Trial (Cryo-ICM AF study)

Clinical application of novel Achieve circular mapping catheter in cryo-ablation of atrial fibrillation